Cargando…

Apelin Inhibits Angiotensin II-Induced Atrial Fibrosis and Atrial Fibrillation via TGF-β1/Smad2/α-SMA Pathway

BACKGROUND: Angiotensin II (Ang II) could promote the development of atrial fibrosis in atrial fibrillation (AF). Apelin can inhibit the occurrence of myocardial fibrosis. However, the effect of apelin on Ang II-induced atrial fibrosis and subsequent AF still remains unknown. OBJECTIVE: In the prese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Wenkui, Zhang, Ling, Cheng, Xinchun, Wang, Hongli, Qin, Wen, Zhou, Xianhui, Tang, Baopeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711167/ https://www.ncbi.nlm.nih.gov/pubmed/33329030 http://dx.doi.org/10.3389/fphys.2020.583570

Ejemplares similares

Elevated β1-Adrenergic Receptor Autoantibody Levels Increase Atrial Fibrillation Susceptibility by Promoting Atrial Fibrosis
por: Shang, Luxiang, et al.
Publicado: (2020)

Ethnicity and anticoagulation management of hospitalized patients with atrial fibrillation in northwest China
por: Cheng, Xinchun, et al.
Publicado: (2017)

Low-Level Vagus Nerve Stimulation Reverses Obstructive Sleep Apnea-Related Atrial Fibrillation by Ameliorating Sympathetic Hyperactivity and Atrial Myocyte Injury
por: Guo, Yankai, et al.
Publicado: (2021)

Regional and temporal progression of atrial remodeling in angiotensin II mediated atrial fibrillation
por: Jansen, Hailey J., et al.
Publicado: (2022)

PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin‐II by reducing TGF‐β1/Smads pathway activation
por: Hu, Juan, et al.
Publicado: (2021)

Ganglionated Plexi Ablation Suppresses Chronic Obstructive Sleep Apnea-Related Atrial Fibrillation by Inhibiting Cardiac Autonomic Hyperactivation
por: Zhang, Ling, et al.
Publicado: (2021)

Irisin attenuates angiotensin II-induced atrial fibrillation and atrial fibrosis via LOXL2 and TGFβ1/Smad2/3 signaling pathways
por: Wu, Yingbiao, et al.
Publicado: (2023)

Salidroside attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II through inhibition of LOXL2-TGF-β1-Smad2/3 pathway
por: Hai, Zhen, et al.
Publicado: (2023)

TGF-β/Smad signaling in renal fibrosis
por: Meng, Xiao-Ming, et al.
Publicado: (2015)

Fibrosis in Atrial Fibrillation – Role of Reactive Species and MPO
por: Friedrichs, Kai, et al.
Publicado: (2012)

Chronic Kidney Disease Increases Atrial Fibrillation Inducibility: Involvement of Inflammation, Atrial Fibrosis, and Connexins
por: Qiu, Huiliang, et al.
Publicado: (2018)

Impact of contact force technology on reducing the recurrence and major complications of atrial fibrillation ablation: A systematic review and meta-analysis
por: Zhou, Xianhui, et al.
Publicado: (2017)

Apelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis
por: Salska, Agata, et al.
Publicado: (2018)

Association of Obesity Measures with Atrial Fibrillation Recurrence After Cryoablation in Patients with Paroxysmal Atrial Fibrillation
por: Shang, Luxiang, et al.
Publicado: (2020)

Apelin increases atrial conduction velocity, refractoriness, and prevents inducibility of atrial fibrillation
por: Kim, Young M., et al.
Publicado: (2020)

Proteomic Analysis of Atrial Appendages Revealed the Pathophysiological Changes of Atrial Fibrillation
por: Liu, Ban, et al.
Publicado: (2020)

Image-Based Computational Evaluation of the Effects of Atrial Wall Thickness and Fibrosis on Re-entrant Drivers for Atrial Fibrillation
por: Roy, Aditi, et al.
Publicado: (2018)

Presence of Left Atrial Fibrosis May Contribute to Aberrant Hemodynamics and Increased Risk of Stroke in Atrial Fibrillation Patients
por: Paliwal, Nikhil, et al.
Publicado: (2021)

Wavelength and Fibrosis Affect Phase Singularity Locations During Atrial Fibrillation
por: Saha, Mirabeau, et al.
Publicado: (2018)

Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation
por: Bayer, Jason D., et al.
Publicado: (2019)

Risk of New-Onset Atrial Fibrillation Post-cavotricuspid Isthmus Ablation in Typical Atrial Flutter Without History of Atrial Fibrillation
por: Li, Jia-hui, et al.
Publicado: (2021)

Atrial fibrillation and microRNAs
por: Santulli, Gaetano, et al.
Publicado: (2014)

Cerebrovascular Dysfunction in Atrial Fibrillation
por: Junejo, Rehan T., et al.
Publicado: (2020)

Immune remodeling and atrial fibrillation
por: Yao, Yajun, et al.
Publicado: (2022)

Premature atrial contractions: A predictor of atrial fibrillation and a relevant marker of atrial cardiomyopathy
por: Guichard, Jean-Baptiste, et al.
Publicado: (2022)

Inhibition of Adenosine Pathway Alters Atrial Electrophysiology and Prevents Atrial Fibrillation
por: Soattin, Luca, et al.
Publicado: (2020)

Linking Electrical Drivers With Atrial Cardiomyopathy for the Targeted Treatment of Atrial Fibrillation
por: Ho, Gordon, et al.
Publicado: (2020)

Slow Conduction in the Border Zones of Patchy Fibrosis Stabilizes the Drivers for Atrial Fibrillation: Insights from Multi-Scale Human Atrial Modeling
por: Morgan, Ross, et al.
Publicado: (2016)

Nitric Oxide Synthases and Atrial Fibrillation
por: Bonilla, Ingrid M., et al.
Publicado: (2012)

An Introduction to Murine Models of Atrial Fibrillation
por: Riley, Genna, et al.
Publicado: (2012)

Arrhythmogenic Substrates for Atrial Fibrillation in Obesity
por: Lubbers, Ellen R., et al.
Publicado: (2018)

Role of Inflammation in the Pathogenesis of Atrial Fibrillation
por: Ihara, Kensuke, et al.
Publicado: (2022)

Clinical Effects of “Selective Drug” Regulating Vagus Nerve Signal Pathway in Vagally-Mediated Atrial Fibrillation
por: Lou, Xue, et al.
Publicado: (2018)

Rapid Atrial Pacing Promotes Atrial Fibrillation Substrate in Unanesthetized Instrumented Rats
por: Mulla, Wesam, et al.
Publicado: (2019)

Higher Incidence of Atrial Fibrillation in Left Ventricular-to-Right Atrial Shunt Patients
por: Chou, Hongda, et al.
Publicado: (2020)

Epicardial Fibrosis Explains Increased Endo–Epicardial Dissociation and Epicardial Breakthroughs in Human Atrial Fibrillation
por: Gharaviri, Ali, et al.
Publicado: (2020)

Time Series Gene Expression Profiling and Temporal Regulatory Pathway Analysis of Angiotensin II Induced Atrial Fibrillation in Mice
por: Wu, Yu-Xuan, et al.
Publicado: (2019)

Left Atrial Hypertension, Electrical Conduction Slowing, and Mechanical Dysfunction – The Pathophysiological Triad in Atrial Fibrillation-Associated Atrial Cardiomyopathy
por: Eichenlaub, Martin, et al.
Publicado: (2021)

Left Atrial Enhancement Correlates With Myocardial Conduction Velocity in Patients With Persistent Atrial Fibrillation
por: Ali, Rheeda L., et al.
Publicado: (2020)

Localized Pulmonary Vein Scar Promotes Atrial Fibrillation in High Left Atrial Pressure
por: Gottlieb, Lisa A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1396e27uvc9tis5t2qnadcmb68